Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA binding motif protein 17 pseudogene 2 (RBM17P2) is a genomic pseudogene that shares sequence similarity with RBM17, a protein coding gene. RBM17P2 does not encode a functional protein and is not associated with any known biological activity, disease roles, or therapeutic targeting. In contrast, the functional gene RBM17 (not RBM17P2) is involved in RNA splicing and has been implicated in cancer progression, but RBM17P2 is not directly relevant as a molecular target. Key Clarification: RBM17P2 is annotated as a pseudogene—meaning it is a non-coding genetic element and not a therapeutic target. If the intended molecule was RBM17 (without the pseudogene designation), please specify, as only that gene currently has established biological activity and disease associations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA binding motif protein 17 pseudogene 2 (RBM17P2).